Christina M. Ackermann
2019
In 2019, Christina M. Ackermann earned a total compensation of $3.4M as Executive Vice President, General Counsel and Head of Commercial Operations at Valeant Pharmaceuticals International, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $806,400 |
|---|---|
| Option Awards | $525,050 |
| Salary | $690,308 |
| Stock Awards | $1,343,982 |
| Other | $14,192 |
| Total | $3,379,932 |
Ackermann received $1.3M in stock awards, accounting for 40% of the total pay in 2019.
Ackermann also received $806.4K in non-equity incentive plan, $525.1K in option awards, $690.3K in salary and $14.2K in other compensation.
Rankings
In 2019, Christina M. Ackermann's compensation ranked 3,624th out of 13,971 executives tracked by ExecPay. In other words, Ackermann earned more than 74.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,624 out of 13,971 | 74th |
Division Manufacturing | 1,309 out of 5,701 | 77th |
Major group Chemicals And Allied Products | 455 out of 2,200 | 79th |
Industry group Drugs | 381 out of 1,886 | 80th |
Industry Pharmaceutical Preparations | 286 out of 1,398 | 80th |
Source: SEC filing on May 2, 2022.
Ackermann's colleagues
We found three more compensation records of executives who worked with Christina M. Ackermann at Valeant Pharmaceuticals International in 2019.